BLOG: Treating Addiction Using Genetic Testing As A Guide

By |2017-12-21T13:59:32-08:00December 21st, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Written by Dr. Bruce Kehr Psychiatrists are using genetic testing to determine which prescription medications work best for treating each patient’s particular addiction. For example, doctors can test patients who suffer from alcohol addiction for variants in a gene called the μ-Opioid Receptor (OPRM1), which has been linked to a [...]

AFSP: Can Ketamine Rapidly Reduce Suicidal Ideation?

By |2021-11-11T17:07:05-08:00June 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

This work was sponsored by a Young Investigator Grant from the American Foundation for Suicide Prevention (AFSP) BACKGROUND Suicide is preventable, yet still remains a worldwide cause of death in part due to a lack of available medical interventions that can work during a suicidal crisis. Most potentially helpful medications [...]

Arthritis Drug Can Boost Antidepressant Effect

By |2016-11-13T17:51:47-08:00November 13th, 2016|We Know Psychiatry|

Giving severely depressed patients the arthritis drug celecoxib (brand name Celebrex) dramatically boosted the effectiveness of their antidepressant medication, according to new research. Patients were randomly assigned to receive the antidepressant escitalopram (Lexapro) plus celecoxib or Lexapro plus a placebo. The study found that 78 percent of the patients in the [...]

Title

Go to Top